The global metagenomics sequencing market size was US$ 1139.3 million in 2021. The global metagenomics sequencing market is forecast to grow to US$ 3,994.01 million by 2030 by registering a compound ...
The US Food and Drug Administration cleared a number of molecular tests and immunoassays, as well as a clinical chemistry and a cellular deformation test.
Pipettes? Check. Centrifuges? Check. Microplates? Check. Gloves? Check. Salmon sperm DNA? Check. Wait what? There are a ...
Abstract: Conventional microarray-based biosensors can only detect a limited number of organisms, and adding sensor capabilities requires re-engineering of reagents and devices to detect the presence ...
With an estimated more than 10 million cases, India accounts for nearly 20% of the global epilepsy burden. The number of ...
The global advanced dermatology drug delivery devices market size was US$ 3,569.9 million in 2021. The global advanced dermatology drug delivery devices market size is forecast to reach US$ 8,785.0 ...
The global protein chip market size is valued at USD 2.36 billion in 2025 and is predicted to hit around USD 4.98 billion by ...
With over a decade of experience architecting and operating large-scale cloud environments across AWS, Azure, and Google ...
Whole Genome Amplification (WGA) offers vast opportunities in personalized medicine, cancer research, and reproductive health ...
Medical Device Network on MSN
Vaxxas gains Australia’s TGA licence to manufacture HD microarray patch
Vaxxas has received a manufacturing licence from Australia’s Therapeutic Goods Administration (TGA) for its high-density microarray patch (HD-MAP) for clinical studies at a biomedical facility in ...
Australian biotech innovator Vaxxas has secured a major milestone in its journey to revolutionise vaccine delivery. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback